Epigenomics AG

ECX
Real-time TRADEGATE AG - 03/26 09:09:45 am
1.701EUR
-1.28%
Prev.1.7080
Open1.6820
High1.7180
Low1.6820
Volume3 500
Financials
Sales 2018 3,19 M
EBIT 2018 -13,9 M
R. net 2018 -14,0 M
Tréso. 2018 16,8 M
Rend. 2018 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales 2018 13,8x
EV / Sales 2019 4,62x
Capitalization 61,0 M
Company
Epigenomics AG is a Germany-based molecular diagnostics company focused on blood-based detection, prognosis and monitoring of cancers using deoxyribonucleic acid (DNA) methylation technology. It develops and commercializes blood-based diagnostic products across multiple cancer indications. The...
Sector :
Bio Diagnostics & Testing
Calendar :
2019-03-27 Earnings Release
Trading Rating : -
Investor Rating :
Latest news
03/19EPIGENOMICS AG : Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQ
03/18EPIGENOMICS AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
03/15EPIGENOMICS : U.S. Representatives Payne and Marchant Introduce Bi-Partisan Colorectal Cancer Detection Bill
PU
03/15CORRECTION OF THE CORPORATE NEWS OF MARCH 15, 2019, 12 : 40 pm: Epigenomics AG: ?U.S. Representatives Payne and Marchant Introduce Bi-Partisan Colorectal Cancer Detection Bill
EQ
03/15EPIGENOMICS : U.S. Representatives Payne, Marchant, and Sewell Introduce Bi-Partisan Colorectal Cancer Detection Bill
PU
03/15EPIGENOMICS AG : U.S. Representatives Payne, Marchant, and Sewell Introduce Bi-Partisan Colorectal Cancer Detection Bill
EQ
03/06EPIGENOMICS : terminates collaboration with Chinese licensing partner and announces anticipated revenue growth in 2019 outlook
EQ
03/06EPIGENOMICS AG : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ